Head-to-Head

Krystal Biotech, Inc. Common Stock vs. Repligen Corp

KRYS

Krystal Biotech, Inc. Common Stock

$308.89 -2.19%

VS RGEN

Repligen Corp

$163.81 -3.81%

Krystal Biotech, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

KRYSRGEN
Market Cap $9.15 billion $10.47 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

KRYSRGEN
Short Interest 0.11% 6.30%

KRYS leads on 1 of 1 risk & sentiment factors.

Dig deeper: KRYS overview, KRYS financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.